Clinical evaluation 0f siddha formulation LAGUGANGATHARA CHOORANAM in the management of valinina kazhichal(Irritable bowel syndrome)

Phase 3

Not yet recruiting

• Conditions: Health Condition 1: K929- Disease of digestive system, unspecified

• Registration Number: CTRI/2022/04/041715
• Lead Sponsor: ATIONAL INSTITUTE OF SIDDHA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2022-04-29
• Last Update Posted: 2022-10-17

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Not specified
• Target Recruitment: 50

Inclusion Criteria

patients who have the symptoms of vali nina kazhichal Irritable bowel syndrome such as abdominal pain relieved by defecation incomplete evacuation of stools abdominal bloating altered bowel habits

patients willing to give informed consent that he/ she will conciously stick to thw treatment for 48 days

patient willing to give blood samples before and after treatmene

Exclusion Criteria

pregnency and lactating mother

K/C/O post infectious IBS(cmphylbacter salmonell and shigella

K/C/O IBD inflammatory boel disease

ulcerative colitis

crohns disease

K/C/O colon cancer

K/C/O Lactose intolerence

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
primary outcome is assessed by comparing the reduction of clinical symptoms before and after treatment by using IBSS scaleTimepoint: 1 year

Secondary Outcome Measures

Name	Time	Method
secondary outcome is assessed by the disease realted to age sex socio economic status family history dietry habits etcTimepoint: fourty ninth day